Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Recs

1
Player Avatar rxedoh26 (50.82) Submitted: 1/31/2009 10:28:16 PM : Outperform Start Price: $3.94 ARRY Score: -76.98

going up eventually

Featured Broker Partners


Advertisement